Please login to the form below

Men’s Health Awareness Month

In this November blog, Innovative Trials will be looking at the men's health and the Movember movement which aims at raising awareness around men's health

According to  research , men  are more likely to die six years earlier than women  due  to :

- Mental health

- Prostate cancer

- Testicular cancer

What are the causes for that?  What are the symptoms and what preventive actions can be taken to avoid that?

Read the full blog here

2nd November 2021

Share

Tags

Company Details

Innovative Trials

+44 (0) 1707 378 581

Contact Website

Address:
Innovative Trials Ltd, Innovative House
Avenue One
Letchworth Garden City
Hertfordshire
SG6 2WW
United Kingdom

Latest content on this profile

Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
Kate Shaw, Innovative Trials' Founder & CEM, reflects on the exciting news for patients affected by cancer in the UK.
Innovative Trials
Kate Shaw reflects on Innovative Trials' first US office openings
On Thanksgiving, Kate Shaw, Founder and CEO of Innovative Trials, reflects on the company first US office opening
Innovative Trials
Innovative Trials on the latest ABPI report
Kate Shaw, Innovative Trials Founder & CEO, commented on the latest ABPI report
Innovative Trials
Innovative Trials featuring in a Clinical Trials Arena article
Leanne Keem, Head of Operations and Client Relationship at Innovative Trials, featured in a recent article.
Innovative Trials
Overcoming Patient Recruitment Challenges in Rare Disease Trials
Rare diseases are thought to affect up to 446 million people worldwide. With more than 7,000 rare diseases, most of which are genetic, it’s vital all patients can access new and effective treatments.We know patient recruitment can be challenging even for non-complex trials, but this issue is exacerbated for rare disease studies due to the much smaller patient populations involved. This can lead to lengthy delays in bringing what can be cutting-edge and potentially life-changing therapies to market.With the global rare disease market expected to be worth more than US$547 billion within the next 10 years overcoming these challenges is critical. This webinar will:explore some of the patient recruitment challenges in rare disease studies, particularly relating to sickle cell trialshear from a patient and family member about what it means to live with a rare disease and highlight strategies to accelerate patient recruitment for these specialized trials.Learning ObjectivePatient recruitment challenges in rare disease studiesChallenges in sickle cells studiesFamily/Patient perspectiveAccelerating patient recruitment in rare disease studiesSpeaker 1 - Whitney Taynton - Business Unit Head, Site Enrollment Optimization, Innovative TrialsSpeaker 2 - Donna Dail - Director, Patient Recruitment Programs (Rare Disease)Speaker 3 - Margaret Alege - Patient
Innovative Trials
FREE Live Webinar - Overcoming Patient Recruitment Challenges in Rare Disease Trials
Innovative Trials and Pfizer invite you to attend the live webinar
Innovative Trials